Literature DB >> 25190314

Seroepidemiology of cytomegalovirus infection in pregnant women in Durango City, Mexico.

Cosme Alvarado-Esquivel1, Jesús Hernández-Tinoco, Luis Francisco Sánchez-Anguiano, Agar Ramos-Nevárez, Sandra Margarita Cerrillo-Soto, Sergio Estrada-Martínez, Lucio Martínez-Ramírez, Alma Rosa Pérez-Álamos, Carlos Alberto Guido-Arreola.   

Abstract

BACKGROUND: Cytomegalovirus causes congenital infections all around the world. The seroepidemiology of cytomegalovirus infection in pregnant women in Mexico is largely unknown. We sought to determine the seroprevalence of cytomegalovirus infection in pregnant women in Durango City, Mexico; and to determine seroprevalence association with socio-demographic, clinical and behavioral characteristics of pregnant women.
METHODS: Through a cross-sectional study design, 343 pregnant women were examined for anti-cytomegalovirus IgG and IgM antibodies in Durango City, Mexico. We used a standardized questionnaire to obtain the general characteristics of the pregnant women. Multivariate analysis was performed to determine the association of cytomegalovirus infection with the characteristics of the pregnant women.
RESULTS: Anti-CMV IgG and IgM antibodies were detected in 225 (65.6%) and in none of the 343 pregnant women studied, respectively. Multivariate analysis showed that CMV exposure was associated with increasing age (OR = 1.67; 95% CI: 1.01-2.76; P = 0.04). Other women characteristics including socioeconomic status, education, blood transfusion, transplantation, sexual promiscuity and number of previous pregnancies or deliveries did not show an association with CMV exposure.
CONCLUSIONS: This is the first seroepidemiology study of CMV infection in pregnant women in Mexico. A number of known factors associated with CMV infection were not associated with CMV exposure in the women studied. Further studies to determine routes of CMV infection in pregnant women in Mexico are needed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25190314      PMCID: PMC4161908          DOI: 10.1186/1471-2334-14-484

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


Background

Cytomegalovirus (CMV) is a DNA virus of the Betaherpesvirinae subfamily and Herpesviridae family [1]. CMV is a leading cause of congenital infections all around the world [2-4]. Congenital infections with CMV may be asymptomatic [5] or may lead to hearing impairment, mental retardation, cerebral palsy [6], and neurodevelopmental disabilities [2, 4]. The incidence of congenital CMV infection is about 1%-7% of births [4]. In addition, congenital CMV infection may occur not only in primary but also in non-primary maternal infections [4]. Infections with CMV persist through chronic and latent states of infections [7], and can be reactivated with shedding of infectious virus [1, 8]. Transmission of CMV occurs by person-to-person contact [1]. In addition, CMV infection acquired by blood transfusion may lead to significant complications in immunocompromised individuals [9]. Severe disease including pneumonia, retinitis, hepatitis, encephalitis, and other organ involvements due to CMV in immunocompromised patients have been reported [10]. Very little is known about the seroepidemiology of CMV infection in Mexican populations. We are not aware of any study on the seroepidemiology of CMV infection in pregnant women in Mexico. Therefore, we sought to determine the seroprevalence of CMV infection in pregnant women in Durango City, Mexico. In addition, the socio-demographic, clinical and behavioral characteristics of pregnant women associated with CMV infection were also investigated.

Methods

Study population and study design

Through a cross-sectional study design, we studied pregnant women in a public primary health care center (Clínica de Medicina Familiar, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado) in Durango City, Mexico from April to November 2013. Inclusion criteria for enrollment in the study were: 1) pregnant women; 2) residing in Durango City; 3) aged 15 years and older; and 4) who accepted to participate in the study.

Socio-demographic, clinical and behavioral data

We submitted a standardized questionnaire to obtain socio-demographic, clinical and behavioral characteristics from the pregnant women studied. Socio-demographic data included age, birthplace, residence, occupation, and educational and socio-economic status. Clinical data included obstetric history (month of pregnancy, number of pregnancies, deliveries, cesarean sections and miscarriages), presence of any underlying disease, history of lymphadenopathy, frequent headaches and impairments of memory, reflexes, vision and hearing, and history of hepatitis, blood transfusions, transplants or surgery. Behavioral data included addictions, sexual promiscuity, washing hands before eating, eating away of home (in restaurants and fast food outlets), consumption of unpasteurized milk, untreated water, and unwashed raw vegetables or fruits, foreign travel, and type of flooring at home.

Laboratory tests

Serum samples were obtained from each pregnant women by centrifugation of whole blood. Sera of the women were kept frozen until analyzed. Sera were examined for anti-CMV IgG antibodies by a commercially available enzyme immunoassay “Cytomegalovirus IgG (CMV IgG)” kit (Diagnostic Automation Inc., Calabasas, CA, USA) and for anti-CMV IgM antibodies by a commercially available enzyme immunoassay “Cytomegalovirus IgM (CMV IgM” kit (Diagnostic Automation Inc., Calabasas, CA, USA). The tests were performed following the instructions of the manufacturer. The cut-off values for IgG and IgM seropositivity were obtained as follows: firstly, the mean optical densities of IgG and IgM calibrators were multiplied by the correction factor (0.50-0.55) printed on the label of calibrators to obtained the corrected mean cut-off value: then, we calculated the CMV G and M indexes by dividing the optical density of each sample by the corrected mean cut-off value. A sample was considered positive for IgG or IgM when a CMV G index or a CMV M index was greater than 1.1, respectively. These assays are qualitative, and no quantification of antibody levels were performed.

Ethical aspects

This study was approved by the ethical committee of the Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado in Durango City. The purpose and procedures of the study were explained to all pregnant women, and a written informed consent was obtained from all of them and from the next of kin of minor participants.

Statistical analysis

The statistical analysis was performed with the aid of the software: Epi Info version 7 and SPSS version 15.0. For calculation of the sample size, we used a value of 15,000 as a population size from which the sample was selected, a reference seroprevalence of 89.2% [11] as expected frequency of the factor under study, 3.5% of confidence limits, a design effect of 1.0, one cluster, and a confidence level of 95%. The result of the calculation was 296 subjects. We used the Pearson’s chi square and the Fisher exact test (when values were small) for comparison of the frequencies among groups. Bivariate and multivariate analyses were used to evaluate the association between the characteristics of the women and CMV seropositivity. Variables with a P value equal to or less than 0.10 obtained in the bivariate analysis were included in the multivariate analysis. Odd ratios (OR) and 95% confidence intervals (CI) were calculated by multivariate analysis using the Enter method. A P value less than 0.05 was considered statistically significant.

Results

In total, we enrolled 343 pregnant women. Most of them were born in Durango; their mean age was 28.88 ± 6.12 years (range 15–43 years). General socio-demographic and obstetric characteristics of the pregnant women studied are shown in Table 1. Anti-CMV IgG antibodies were detected in 225 (65.6%) of the 343 pregnant women studied. None of the 343 pregnant women had anti-CMV IgM antibodies.
Table 1

Socio-demographic and obstetric characteristics of pregnant women and seroprevalence of CMV infection

No. of womenPrevalence of CMV infectionP value
Characteristictesteda No.%
Age groups (years)
  15-3019811960.10.009
  31-4314410673.6
Birth place
  Durango State31920965.50.68
  Other Mexican State201470.0
Residence place
  Durango State34222465.51.00
  Other Mexican State11100.0
Residence area
  Urban32521365.50.75
  Suburban5480.0
  Rural13861.5
Educational level
  Up to 6 years11100.00.75
  7-12 years1338866.2
  13 or more years20913665.1
Occupation
  Unemployedb 1106962.70.44
  Employedc 23315667.0
Socio-economic level
  Low191473.70.69
  Medium31620662.5
  High4375.0
Month of pregnancy
  1 to 31177765.80.91
  4 to 615310065.4
  7 to 9664568.2
Deliveries
  Yes1409467.10.59
  No20213064.4
Pregnancies
  3 or more22815869.30.04
  1 or 21156758.3
Cesarean sections
  None24115564.30.47
  1 or 21016968.3
Miscarriages
  None26917364.70.37
  1-3735169.9

aPregnant women with available data.

bUnemployed = none occupation, student or housewife.

cEmployed = Employee, professional, business, or other.

Socio-demographic and obstetric characteristics of pregnant women and seroprevalence of CMV infection aPregnant women with available data. bUnemployed = none occupation, student or housewife. cEmployed = Employee, professional, business, or other. Of the socio-demographic characteristics of the pregnant women (Table 1), only the variable age showed a P value <0.10 by bivariate analysis. Other socio-demographic characteristics including birthplace, residence, educational level, occupation and socio-economic status had P values >0.10 by bivariate analysis. With respect to behavioral characteristics, smoking was the only variable that showed a P value <0.10 by bivariate analysis. Other behavioral characteristics including foreign travel, eating away of home, consumption of untreated water, and unwashed raw vegetables or fruits, drug or alcohol addictions, sexual promiscuity, washing hands before eating, and type of flooring at home show P values >0.10 by bivariate analysis. Concerning clinical characteristics, seroprevalence of CMV infection was similar in ill (7/15: 46.7%) than in healthy (217/327: 66.4%) pregnant women (P = 0.11). In contrast, seroprevalence of CMV infection was significantly higher (P = 0.04) in pregnant women with history of lymphadenopathy (39/50: 78.0%) than in those without such history (186/292: 63.7%). Pregnant women with more than two pregnancies had a significantly higher (P = 0.04) seroprevalence of CMV exposure (158/228: 69.3%) than those with one or two pregnancies (67/115: 58.3%). Other clinical characteristics of pregnant women including impairments of memory, reflexes, vision and hearing, history of hepatitis, blood transfusions, transplants or surgery, and other obstetric characteristics (month of pregnancy, number of deliveries, cesarean sections and miscarriages) were not associated with CMV infection. Multivariate analysis of socio-demographic, clinical and behavioral variables with P values equal to or lower than 0.10 by bivariate analysis (Table 2) showed that CMV infection was positively associated only with age (OR = 1.67; 95% CI: 1.01-2.76; P = 0.04).
Table 2

Multivariate analysis of selected characteristics of pregnant women and their association with CMV infection

CharacteristicOdds ratioa 95%confidence interval Pvalue
Age (31–43 years)1.671.01 - 2.760.04
Lymphadenopathy2.030.98 - 4.190.05
More than 2 pregnancies1.360.81 - 2.260.23
Smoking0.530.26 - 1.070.08

aAdjusted by the characteristics included in this Table.

Multivariate analysis of selected characteristics of pregnant women and their association with CMV infection aAdjusted by the characteristics included in this Table.

Discussion

There is a lack of knowledge about the epidemiology of CMV infection in pregnant women in Mexico. The present study was performed to investigate the seroprevalence and correlates of CMV infection in pregnant women in the northern Mexican city of Durango. We found a 65.6% seroprevalence of CMV infection in the pregnant women studied. Based on the seropositivity to CMV IgG and IgM antibodies, all women with CMV exposure had latent infection and none had recent or acute CMV infection. We are not aware of previous reports about the seroepidemiology of CMV infection in pregnant women in Mexico. Therefore, we cannot compare our seroprevalence results with others in pregnant women in Mexico. In a study in healthy women of reproductive age in Cuernavaca City in central Mexico, researchers found a 92.6% seroprevalence of CMV infection [12]. While in a national survey in subjects aged 1 to 70 years old in Mexico an 88.2% seroprevalence of CMV infection was found [11]. On the other hand, comparison of our seroprevalence with those reported in other countries suggests that the seroprevalence of CMV infection in pregnant women in Durango could be placed in an intermediate position of endemicity. The 65.6% seroprevalence found in pregnant women in Durango is similar to the 62.4%-66% seroprevalences reported in pregnant women in Poland [13], Japan [14], and Norway [15], and higher than the 49% seroprevalence in white British pregnant women in the United Kingdom [16] and a 42.3% seroprevalence in pregnant women in Germany [17]. In contrast, the seroprevalence found in pregnant women in Durango is lower than the 92.6%-100% seroprevalences reported in pregnant women in Iran [18], Palestine [19], Brazil [20], Turkey [21], Nigeria [22], and Cuba [23]. Analysis of the socio-demographic characteristics showed that the seroprevalence of CMV infection in pregnant women increased with age. This finding is consistent with those reported in other studies where researchers found an increase in the seroprevalence of CMV infection with age in both pregnant women [13] and general population [24]. Other known contributing factors for CMV infection including socioeconomic status [8], education, sexual promiscuity [12], blood transfusion and transplantation [25] did not show any association with CMV exposure in the women studied. Of the sources of infection with CMV in pregnant women stands out young children [26, 27]. We assess the contact with young children by evaluating the number of children the women have already born (history of pregnancies), considering that women with more than two pregnancies had a higher contact with children than women with fewer pregnancies. Analysis showed that women with more than two pregnancies had a higher, but not statistically significant, seroprevalence of CMV infection than those with one or two pregnancies. This approach was a limitation of the study since contact with children can occur not only at home but also at work in some women. In the present study, the occupation of housewife was not associated with CMV exposure. None of the pregnant women studied reported to be schoolteacher or baby-sitter and the lack of these occupations among the studied women might have a negative influence on the seroprevalence. Therefore, the association of CMV exposure with contact with children should be further evaluated in pregnant women in Mexico. Hygiene practices are important in the prevention of CMV infection [26]. However, in this study the variable washing hands before eating did not show an association with CMV exposure.

Conclusions

This is the first seroepidemiology study of CMV infection in pregnant women in Mexico. A number of known factors associated with CMV infection were not associated with CMV exposure in the women studied. Further studies to determine routes of CMV infection in pregnant women in Mexico are needed.
  27 in total

1.  Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996-2010.

Authors:  Gisela Enders; Anja Daiminger; Lisa Lindemann; Frank Knotek; Ursula Bäder; Simone Exler; Martin Enders
Journal:  Med Microbiol Immunol       Date:  2012-03-08       Impact factor: 3.402

2.  Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.

Authors:  Carlos Conde-Glez; Eduardo Lazcano-Ponce; Rosalba Rojas; Rodrigo DeAntonio; Luis Romano-Mazzotti; Yolanda Cervantes; Eduardo Ortega-Barria
Journal:  Vaccine       Date:  2013-09-07       Impact factor: 3.641

3.  Seroprevalence of cytomegalovirus infection in the United States, 1988-1994.

Authors:  Stephanie A S Staras; Sheila C Dollard; Kay W Radford; W Dana Flanders; Robert F Pass; Michael J Cannon
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

Review 4.  Human cytomegalovirus persistence.

Authors:  Felicia Goodrum; Katie Caviness; Patricia Zagallo
Journal:  Cell Microbiol       Date:  2012-03-08       Impact factor: 3.715

5.  Changes in cytomegalovirus seroprevalence in pregnant Japanese women-a 10-year single center study.

Authors:  Kosuke Taniguchi; Noriyoshi Watanabe; Anna Sato; Seung Chik Jwa; Tomo Suzuki; Yuji Yamanobe; Haruhiko Sago; Kazuto Kozuka
Journal:  J Clin Virol       Date:  2014-01-08       Impact factor: 3.168

Review 6.  Cytomegalovirus infection in pregnancy.

Authors:  B D Raynor
Journal:  Semin Perinatol       Date:  1993-12       Impact factor: 3.300

7.  Seroprevalence of cytomegalovirus antibodies amongst normal pregnant women in Nigeria.

Authors:  Akinsegun Abduljaleel Akinbami; Kabiru Afolarin Rabiu; Adeniyi Abiodun Adewunmi; Kikelomo Ololade Wright; Adedoyin Owolabi Dosunmu; Titilope Adenike Adeyemo; Adewumi Adediran; Vincent Oluseye Osunkalu
Journal:  Int J Womens Health       Date:  2011-12-16

8.  Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study.

Authors:  Lucy Pembrey; Pauline Raynor; Paul Griffiths; Shelley Chaytor; John Wright; Andrew J Hall
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

9.  Seroprevalence of Cytomegalovirus among pregnant women and hospitalized children in Palestine.

Authors:  Tahani Neirukh; Ayda Qaisi; Niveen Saleh; Areej Abu Rmaileh; Eman Abu Zahriyeh; Lina Qurei; Firas Dajani; Taghreed Nusseibeh; Hatem Khamash; Sabri Baraghithi; Maysa Azzeh
Journal:  BMC Infect Dis       Date:  2013-11-09       Impact factor: 3.090

10.  Early high CMV seroprevalence in pregnant women from a population with a high rate of congenital infection.

Authors:  A Y Yamamoto; R A C Castellucci; D C Aragon; M M Mussi-Pinhata
Journal:  Epidemiol Infect       Date:  2012-12-03       Impact factor: 4.434

View more
  6 in total

1.  Lack of Association Between Cytomegalovirus Infection and Hypertensive Disorders in Pregnancy: A Case-Control Study in Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Ada A Sandoval-Carrillo; Fernando Vazquez-Alaniz; José M Salas-Pacheco; Jesús Hernández-Tinoco; Luis Francisco Sánchez-Anguiano; Elizabeth Irasema Antuna-Salcido
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2017-07-13

Review 2.  Seroprevalence of Cytomegalovirus among Women of Reproductive Age in Iran: A Systematic Review and Meta-Analysis.

Authors:  Maedeh Sharghi; Hadis Musavi; Shabnam Malekpour Mansurkhani; Wesam Kooti; Masoud Behzadifar; Hadis Ashrafi-Zadeh; Milad Azami; Roonak Shahooei; Hajar Kashefi; Leila Jouybari
Journal:  Iran J Public Health       Date:  2019-02       Impact factor: 1.429

3.  A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development.

Authors:  Witold Lewandowski; Carla Talarico; Karen Fowler; Jacek Mucha; Monika Neumann; Magdalena Kaczanowska; Maciej Grys; Elvira Schmidt; Andrew Natenshon; Philip O Buck; John Diaz-Decaro
Journal:  BMC Public Health       Date:  2022-09-01       Impact factor: 4.135

4.  Rubella Immune Status in Pregnant Women in a Northern Mexican City.

Authors:  Cosme Alvarado-Esquivel; Jesus Hernandez-Tinoco; Luis Francisco Sanchez-Anguiano; Agar Ramos-Nevarez; Sandra Margarita Cerrillo-Soto; Jose Manuel Salas-Pacheco; Ada Agustina Sandoval-Carrillo; Lucio Martinez-Ramirez; Elizabeth Irasema Antuna-Salcido; Carlos Alberto Guido-Arreola
Journal:  J Clin Med Res       Date:  2016-07-30

5.  Seroepidemiology of Cytomegalovirus Infection in Pregnant Women in the Central Mexican City of Aguascalientes.

Authors:  Cosme Alvarado-Esquivel; Maria Del Carmen Terrones-Saldivar; Jesus Hernandez-Tinoco; Maria Daniela Enriqueta Munoz-Terrones; Roberto Oswaldo Gallegos-Gonzalez; Luis Francisco Sanchez-Anguiano; Martha Elena Reyes-Robles; Elizabeth Irasema Antuna-Salcido
Journal:  J Clin Med Res       Date:  2018-02-18

6.  Seroprevalence of HIV, HTLV, CMV, HBV and rubella virus infections in pregnant adolescents who received care in the city of Belém, Pará, Northern Brazil.

Authors:  Aubaneide Batista Guerra; Leonardo Quintão Siravenha; Rogério Valois Laurentino; Rosimar Neris Martins Feitosa; Vânia Nakauth Azevedo; Antonio Carlos Rosário Vallinoto; Ricardo Ishak; Luiz Fernando Almeida Machado
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-16       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.